Convergent Bio
PrivateLast Round
Accelerator
Aug 22, 2024
Company Overview
Convergent Bio is an agtech company that develops sustainable agriculture technologies using a multidisciplinary approach of bioconvergence, biodelivery, and biosystems.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convergent Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Convergent Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 22, 2024 |
Convergent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Topeka | Accelerator |
Convergent Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Convergent Bio's valuation, stock price, and market status.